Funding opportunities

This is a funding notice board for those looking for assistance in their diagnostics development. This will initially host many UK based funders that fund UK and international teams, but we will be researching and adding more funders based in other countries as well. To add an opportunity, longitude [dot] prize [at] nesta [dot] org [dot] uk (please email us).
To see more funding resources, such as general databases and websites, visit our Resources page
Filters

MoST - UK-China collaboration to tackle AMR

The Ministry of Science and Technology (MoST) will provide up to 5 million RMB funding to the Chinese members. This will be in bilateral research and development (R&D) projects between the UK and China. The funding will address the growing threat of antimicrobial resistance (AMR). This competition is for innovative projects that support the development and, where appropriate, clinical...
AMR, Diagnostics
Deadline 30 May 2018

Innovate UK - UK-China collaboration to tackle AMR

UK researchers can apply for a share of up to £10 million for joint projects with Chinese partners to tackle antimicrobial resistance (AMR). The Department of Health and Social Care (DHSC) is working with Innovate UK to invest up to £10 million of Official Development Assistance (ODA) funding. This will be in bilateral research and development (R&D) projects between the UK and China. The...
AMR, Diagnostics
Deadline 30 May 2018

NIHR - i4i Product Development Awards

These awards support any stage of the translational research and development pathway, including the clinical development of laboratory-validated technologies or interventions. A minimum of two organisations must be involved from either NHS Trust, HEI or SME, lead applicants must be based in England, projects may be up to three years in duration. There is no upper funding limit, but costs must be...
Diagnostics, Technology
Duration Up to 36 Months
Deadline 6 June 2018

Biomedical Catalyst 2018 round 1: early stage award

The aim of the Biomedical Catalyst is to support the development of innovative healthcare products, technologies and processes. This is a competition for an early stage award in the Biomedical Catalyst. SMEs can apply for a share of up to £8 million to continue a project's early stage development and technical evaluation, up to readiness for clinical testing. The aim of the early stage award...
Diagnostics, Proof-of-concept
Duration 12 - 36 Months
Deadline 6 June 2018

Pages